Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 1(24), p. 79-86, 2021
DOI: 10.1080/13696998.2020.1857960
Links
Tools
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer
Journal article published in 2020 by
Joshua A. Roth 
,
Yong Yuan,
Megan Othus,
Mark Danese ,
Samuel Wagner,
John R. Penrod,
Scott D. Ramsey
,
Yong Yuan,
Megan Othus,
Mark Danese ,
Samuel Wagner,
John R. Penrod,
Scott D. Ramsey
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 